ABSTRACT
INTRODUCTION
Myelodysplastic syndromes (MDS) describe a heterogeneous group of malignant hematopoietic stem cell disorders which characterized by dysplastic and ineffective blood cell production and a variable risk of transformation to acute leukemia. Because of a variable reduction in production of normal blood cells, a variety of systemic consequences including anemia, bleeding, and an increased risk of infection may occur . 1 A wide spectrum of autoimmune manifestations is reported in myelodysplastic syndromes. 2 There are some case reports and series indicating the association of MDS with inflammatory arthritis [3] [4] [5] [6] [7] or vasculitis syndromes. [8] [9] [10] In some cases, drugs such as hydroxychloroquine and azathioprine were considered as corresponding factors. 3, 11 Patients with inflammatory arthritis and cytopenia are often diagnosed with SLE, RA (felty's syndrome) or sarcoidosis, but clinician should remember that it may be a combination of inflammatory arthritis and MDS. Thus, careful examination by a hematologist is recommended. The study was designed to determine the association between rheumatologic disorders and MDS. 
MATERIALS AND METHODS

23
RESULTS
This cross sectional study surveyed the characteristics of inflammatory arthritis in patients with MDS in hematology and rheumatology clinics in Sari, Iran. Thirty-six (45%) of 80 patients enrolled in the study were females. The mean age was 57.9±18-81 years. Systemic or metabolic disorders included diabetes mellitus, hyperlipidemia, hypothyroidism, renal failure in 10(12.5%), 16(20%), 16(20%), 10(12.5%) of participants, respectively.
The subtypes of MDS included RC in 28 (35%), RARS in 1 (1.3%), RCMD in 47 (58.8%), RAEB1 in 3 (3.8%) and RAEB2 in 1 (1.3%). Inflammatory rheumatologic disorders were detected in 9 (11.3%) of cases. The subtypes of MDS in these patients included RC in 4 (44.4%), RCMD in 4 (44.4%) and RAEB1 in 1 (11.1%). No significant difference was found in hematologic parameters including white blood cell count (WBC), hemoglobin (Hg), red blood cell count (RBC) and platelet count between the two groups (p>0.05).Various types of inflammatory rheumatologic disorders may be associated with MDS (Table 1) . RCMD: Refractory cytopenia with multilinage dysplasia, RC: Refractory cytopenia, RAEB 1: Refractory anemia with excess blast 1. Demographic data and underling disease in MDS patients with and without rheumatologic disorders were compared in Table 2 . 4, 5 But in a recent study conducted by Mekinian, 22 patients with MDS were evaluated for inflammatory arthritis and polyarthritis was diagnosed in 17 (77%) cases. 6 Inflammatory arthritis was recorded between 5.4 and 77% in patients with MDS. [4] [5] [6] It may be because of methods for classification and diagnosis or duration of disease. There are some kinds of immunological abnormalities in patients with MDS, including defective B-and T-cell function, hyper or hypogammaglobulinemia and monoclonal gammopathy. Positive antinuclear antibody and positive direct Coombs test or inverted CD4/8 ratios were found in 18-65% of patients with MDS. 12, 13 Considering the unavailability of cytogenetic study in our center, we suggest future surveys on the association of rheumatologic disorders in MDS patients with different kinds of cytogenetic anomalies. CONCLUSION The findings of this study indicate that rheumatologic manifestations may be present in MDS patients. Younger patients are more prone to the occurrence of MDS and rheumatic disorders.
